title: Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease.
authors.forename: Dario
authors.initials: D
authors.lastname: Benincasa
authors.forename: Clelia
authors.initials: C
authors.lastname: Pellicano
authors.forename: Alessandra
authors.initials: A
authors.lastname: Fanciulli
authors.forename: Francesco E
authors.initials: FE
authors.lastname: Pontieri
mesh_terms: D000328:Adult; D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use*; D003192:Compulsive Behavior / Q000139:chemically induced / Q000188:drug therapy*; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000978:Antiparkinson Agents; D018765:Dopamine Uptake Inhibitors; D016642:Bupropion; D007980:Levodopa